Published in Am J Gastroenterol on March 01, 2008
Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol (2010) 1.95
Investigation of susceptibility genes triggering lachrymal/salivary gland lesion complications in Japanese patients with type 1 autoimmune pancreatitis. PLoS One (2015) 1.41
Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol (2008) 1.18
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
PRSS1_p.Leu81Met mutation results in autoimmune pancreatitis. World J Gastroenterol (2013) 0.91
Pathophysiology of autoimmune pancreatitis. World J Gastrointest Pathophysiol (2014) 0.88
Autoimmune pancreatitis--a new evolving pancreatic disease? Langenbecks Arch Surg (2010) 0.88
The great mimicker: IgG4-related disease. Clin Rheumatol (2013) 0.84
Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol (2010) 0.84
Commensal Flora, is it an Unwelcomed Companion as a Triggering Factor of Autoimmune Pancreatitis? Front Physiol (2012) 0.84
Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms. J Negat Results Biomed (2008) 0.83
Treatment and relapse of autoimmune pancreatitis. Gut Liver (2008) 0.82
IgG4-related sclerosing cholangitis: all we need to know. J Gastroenterol (2016) 0.82
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update. Auto Immun Highlights (2010) 0.81
IgG4-related hepatobiliary disease: an overview. Nat Rev Gastroenterol Hepatol (2016) 0.78
Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity. Genet Test Mol Biomarkers (2013) 0.78
Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians. Springerplus (2013) 0.78
Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis. J Gastroenterol (2014) 0.77
Are dysregulated inflammatory responses to commensal bacteria involved in the pathogenesis of hepatobiliary-pancreatic autoimmune disease? An analysis using mice models of primary biliary cirrhosis and autoimmune pancreatitis. ISRN Gastroenterol (2011) 0.77
Autoantibodies in autoimmune pancreatitis. Int J Rheumatol (2012) 0.77
Are regulatory molecules for T cells involved in the development of autoimmune pancreatitis? Am J Gastroenterol (2008) 0.77
Quantitative Trait Locus Analysis Implicates CD4⁺/CD44high Memory T Cells in the Pathogenesis of Murine Autoimmune Pancreatitis. PLoS One (2015) 0.76
Recent advances in autoimmune pancreatitis. Gastroenterol Hepatol (N Y) (2008) 0.75
Autoimmune pancreatitis. Gland Surg (2016) 0.75
Autoimmune Pancreatitis. Gastroenterol Rep (2013) 0.75
An overview of the diagnosis and management of immunoglobulin G4-related disease. CMAJ (2016) 0.75
From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis. Gastroenterol Res Pract (2017) 0.75
In vitro studies implicate an imbalanced activation of dendritic cells in the pathogenesis of murine autoimmune pancreatitis. Oncotarget (2016) 0.75
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04
Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet (2010) 2.74
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology (2008) 2.70
Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet (2002) 2.69
Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol (2007) 2.60
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology (2004) 2.40
Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol (2008) 2.31
Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol (2010) 2.25
Operative morbidity of living liver donors in Japan. Lancet (2003) 2.13
Japanese clinical guidelines for autoimmune pancreatitis. Pancreas (2009) 2.11
Development of small hepatocellular carcinoma in a patient with chronic hepatitis C after 77 months of a sustained and complete response to interferon therapy. J Gastroenterol Hepatol (2002) 2.07
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer (2004) 2.03
Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation (2002) 2.01
Mechanisms of lower bile duct stricture in autoimmune pancreatitis. Pancreas (2014) 1.98
HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology (2002) 1.92
Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc (2005) 1.81
Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci (2012) 1.72
Safety and driving ability following low-dose propofol sedation. Digestion (2008) 1.66
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. Helicobacter (2002) 1.65
PPARalpha protects proximal tubular cells from acute fatty acid toxicity. J Am Soc Nephrol (2007) 1.62
Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60
Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology (2007) 1.58
A case of Mikulicz's disease complicated by malignant lymphoma: a postmortem histopathological finding. Intern Med (2012) 1.56
Leptin and leptin receptor gene polymorphisms in obstructive sleep apnea syndrome. Chest (2007) 1.55
PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest (2008) 1.55
Genetics of Behçet disease inside and outside the MHC. Ann Rheum Dis (2009) 1.55
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients. Hepatol Res (2005) 1.51
ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc (2002) 1.47
Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol (2009) 1.47
Psychomotor recovery and blood propofol level in colonoscopy when using propofol sedation. Gastrointest Endosc (2011) 1.45
Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study. J Gastroenterol (2007) 1.45
Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol (2009) 1.44
Idiopathic myelofibrosis with refractory massive ascites. Intern Med (2003) 1.43
Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci (2008) 1.43
Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography. Dig Endosc (2012) 1.41
Rapid evolution of major histocompatibility complex class I genes in primates generates new disease alleles in humans via hitchhiking diversity. Genetics (2006) 1.37
Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol (2008) 1.33
Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol (2004) 1.32
Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology (2010) 1.28
IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med (2006) 1.28
Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas (2006) 1.26
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol (2014) 1.26
Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin Infect Dis (2008) 1.25
Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene. J Pathol (2004) 1.20
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol (2002) 1.18
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis (2003) 1.18
The COL1A1 gene and high myopia susceptibility in Japanese. Hum Genet (2007) 1.17
Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation (2005) 1.16
Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress. J Hepatol (2009) 1.16
Autoimmune pancreatitis and complement activation system. Pancreas (2006) 1.15
Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant (2003) 1.12
Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet (2002) 1.11
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci (2005) 1.10
Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res (2007) 1.10
Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection. J Hepatol (2010) 1.09